Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Orally soluble ondansetron pellicles to prevent postoperative nausea and vomiting after total joint arthroplasty
ChiCTR2400088859Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ondansetron in postoperative nausea and vomiting (PONV) (3 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: postoperative nausea and vomiting. Planned start Sep 2024; status: not yet recruiting.
02
Drugs
ondansetron
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on ChiCTR2400088859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400088859.